Identification of a domain in human immunodeficiency virus type 1 Rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11899-11910

  D'Agostino, D M ^a   Ferro, T ^a   Zotti, L ^a   Meggio, F ^a   Pinna, L A ^a   Chieco Bianchi, L ^a   Ciminale, V ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MESSENGER RNA; REV PROTEIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; RNA SPLICING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; BIOLOGICAL TRANSPORT; CELL NUCLEUS; GENE PRODUCTS, REV; GENES, REV; HELA CELLS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 0034466809     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11899-11910.2000     Document Type: Article

References (85)

1. Helix-loop-helix motif in HIV-1 Rev
2. α helix-major groove recognition in an HIV-1 Rev peptide-RRE RNA complex
3. Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting rev-responsive element does not affect the fate of viral mRNA
4. Coupling RNA polymerase II transcription with pre-mRNA processing
5. Cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations
6. Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and splicing factor SC-35
7. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins
8. Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated beta-subunits
9. Efficient autophosphorylation and phosphorylation of the beta-subunit by casein kinase-2 require the integrity of an acidic cluster 50 residues downstream from the phosphoacceptor site
10. Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3′ ends of labile mRNA
11. Mammalian nuclei contain foci which are highly enriched in components of the pre-mRNA splicing machinery
12. Transcription-dependent colocalization of the U1, U2, U4/U6, and U5 snRNPs in coiled bodies
13. Regulation by HIV Rev depends on recognition of splice sites
14. 5,6-Dichloro-1-βD-ribofuranosylbenzimidazole inhibits transcriptional elongation by RNA polymerase II in vivo
15. Solution oligomerization of the Rev protein of HIV-1: Implications for function
16. Characterization of HIV-1 Rev protein: Binding stoichiometry and minimal RNA substrate
17. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: Involvement of continued rRNA synthesis in nuclear retention
18. Biochemical characterization of binding of multiple Rev monomeric proteins to the Rev responsive element
19. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA
20. The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein
21. Nuclear export of RNAs by herpes viruses encoded factors: Old or new routes?
22. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs
23. CRM1 is an export receptor for leucine-rich nuclear export signals
24. A human nucleoporin-like protein that specifically interacts with HIV Rev
25. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus
26. CRM1 is responsible for intracellular transport mediated by the nuclear export signal
27. Human immunodeficiency virus env expression becomes Rev independent if the env region is not defined as an intron
28. The ins and outs of HIV Rev
29. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: Mapping cryptic functions of the arginine-rich motif
30. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: Essential residues near the amino terminus
31. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA
32. The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear components
33. Subcellular distribution of human immunodeficiency virus type 1 Rev and colocalization of Rev with RNA splicing factors in a speckled pattern in the nucleoplasm
34. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev
35. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6 · U5 small nuclear ribonucleoprotein in spliceosome assembly
36. Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein
37. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1
38. Transcription-dependent redistribution of nuclear protein 4.1 to SC35-enriched nuclear domains
39. Structure and function in the nucleus
40. U1 small nuclear RNA plays a direct role in the formation of a Rev-regulated human immunodeficiency virus env mRNA that remains unspliced
41. Localization of human immunodeficiency virus Rev in transfected and virus-infected cells
42. Sequence requirements for Rev multimerization in vivo
43. Functional dissection of the HIV-1 rev trans-activator - Derivation of a trans-dominant repressor of rev function
44. HIV structural gene expression requires the binding of multiple Rev monomers to the vial RRE: Implications for HIV-1 latency
45. Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 ('casein kinase-2')
46. Redistribution of nuclear ribonucleoprotein antigens during herpes simplex virus infection
47. Identification of nuclear and nucleolar localization signals in the herpes simplex virus regulatory protein ICP27
48. Phosphorylation of HIV Rev protein: Implications of protein kinase CK2 and pro-directed kinases
49. Identification of trans-dominant HIV-1 protein mutants by direct transfer of bacterially produced proteins into human cells
50. The HIV-1 Rev transactivator shuttles between the nucleus and the cytoplasm
51. mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription
52. The dynamics of a pre-mRNA splicing factor in living cells
53. Biochemical characterization of HIV-1 Rev as a potent activator of casein kinase II in vitro
54. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids
55. Evidence for a role of CRM1 in signal-mediated nuclear export
56. A herpes simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear ribonucleoprotein distribution
57. The HIV-1 Rev protein
58. HIV Rev-dependent binding of SF2/ASF to the Rev response element: Possible role in Rev-mediated inhibition of HIV RNA splicing
59. HIV-1 Rev is capable of shuttling between the nucleus and the cytoplasm
60. Prediction of protein structure at better than 70% accuracy
61. Combining evolutionary information and neural networks to predict protein secondary structure
62. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation
63. The herpes simplex virus type 1 regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and the C terminus appears to be required for this interaction
64. ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding via intronless RNAs through an RGG motif
65. Basic residues in the 74-83 and 191-198 segments of protein kinase CK2 catalytic subunit are implicated in negative but not in positive regulation by the beta-subunit
66. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1
67. Nuclear organization of pre-mRNA splicing factors
68. Expression and purification of glutathione-S-transferase fusion proteins
69. Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and the cytoplasm mediates the expression of late proteins
70. Immunoelectron microscopic localization of snRNAPs
71. Associations between distinct pre-mRNA splicing components and the cell nucleus
72. Macromolecular domains within the cell nucleus
73. Exportin 1 (Crm1p) is an essential nuclear export factor
74. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: Transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm
75. Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells
76. Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import
77. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants
78. The isolation and analysis of polysomes and ribosomal RNA from cells growing in monolayer culture
79. Probing the structure of the HIV-1 Rev trans-activator protein by functional analysis
80. Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface
81. Identification of a high-affinity RNA binding site for the human immunodeficiency virus type 1 Rev protein
82. Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype
83. Oligomerization and RNA binding domains of the HIV-1 Rev protein: A dual function for an arginine-rich binding motif
84. Flexible regions of RNA structure facilitate co-operative Rev assembly on the Rev-response element